Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis

Pediatric Nephrology

Volumn 28, Issue 2, 2013, Pages 333-338

  Kumar, Juhi ^a   Shatat, Ibrahim F ^b   Skversky, Amy L ^c   Woroniecki, Robert P ^c   Del Rio, Marcela ^c   Perelstein, Eduardo M ^a   Johnson, Valerie L ^a   Mahesh, Shefali ^d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^d AKRON CHILDREN'S HOSPITAL   (United States)

Author keywords

Focal segmental glomerulosclerosis; Plasmapheresis; Proteinuria; Recurrent disease; Transplant

Indexed keywords

BASILIXIMAB; CREATININE; CYCLOSPORIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROTEIN; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ABSENCE OF SIDE EFFECTS; ACUTE KIDNEY TUBULE NECROSIS; ADOLESCENT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG INDUCED DISEASE; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; HUMAN; KIDNEY BIOPSY; LUNG INJURY; MALE; MULTICENTER STUDY; OUTCOME VARIABLE; PEDIATRIC SURGERY; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; PULMONARY HYPERTENSION; RECURRENCE RISK; RECURRENT DISEASE; RENOVASCULAR HYPERTENSION; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOLOGIC FACTORS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; PLASMAPHERESIS; PROTEINURIA; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84875854180     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-012-2314-6     Document Type: Article

References (47)

1. Kitiyakara C, Eggers P, Kopp JB (2004) Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis 44:815-825 (Pubitemid 39445913)
2. Schachter ME, Monahan M, Radhakrishnan J, Crew J, Pollak M, Ratner L, Valeri AM, Stokes MB, Appel GB (2010) Recurrent focal segmental glomerulosclerosis in the renal allograft: single center experience in the era of modern immunosuppression. Clin Nephrol 74:173-181
3. Tejani A, Stablein DH (1992) Recurrence of focal segmental glomerulosclerosis posttransplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 2:S258-S263
4. Dantal J, Godfrin Y, Koll R, Perretto S, Naulet J, Bouhours JF, Soulillou JP (1998) Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome. J Am Soc Nephrol 9:1709-1715 (Pubitemid 28405079)
5. Iharada A, Kaneko K, Tsuji S, Hasui M, Kanda S, Nishiyama T (2009) Increased nitric oxide production by T- and B-cells in idiopathic nephrotic syndrome. Pediatr Nephrol 24:1033-1038
6. Benz K, Dotsch J, Rascher W, Stachel D (2004) Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 19:794-797 (Pubitemid 38931165)
7. Nozu K, Iijima K, Fujisawa M, Nakagawa A, Yoshikawa N, Matsuo M (2005) Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome. Pediatr Nephrol 20:1660-1663 (Pubitemid 41554486)
8. Pescovitz MD, Book BK, Sidner RA (2006) Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment. N Engl J Med 354:1961-1963 (Pubitemid 43872718)
9. Apeland T, Hartmann A (2008) Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation. Nephrol Dial Transplant 23:2091-2094 (Pubitemid 351768185)
10. Bayrakci US, Baskin E, Sakalli H, Karakayali H, Haberal M (2009) Rituximab for post-transplant recurrences of FSGS. Pediatr Transplant 13:240-243
11. Dello Strologo L, Guzzo I, Laurenzi C, Vivarelli M, Parodi A, Barbano G, Camilla R, Scozzola F, Amore A, Ginevri F, Murer L (2009) Use of rituximab in focal glomerulosclerosis relapses after renal transplantation. Transplantation 88:417-420
12. Grenda R, Jarmuzek W, Piatosa B, Rubik J (2011) Long-term effect of rituximab in maintaining remission of recurrent and plasmapheresis-dependent nephrotic syndrome post-renal transplantation - case report. Pediatr Transplant 15:E121-E125
13. Hickson LJ, Gera M, Amer H, Iqbal CW, Moore TB, Milliner DS, Cosio FG, Larson TS, Stegall MD, Ishitani MB, Gloor JM, Griffin MD (2009) Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation 87:1232-1239
14. Nakayama M, Kamei K, Nozu K, Matsuoka K, Nakagawa A, Sako M, Iijima K (2008) Rituximab for refractory focal segmental glomerulosclerosis. Pediatr Nephrol 23:481-485
15. Vinai M, Waber P, Seikaly MG (2010) Recurrence of focal segmental glomerulosclerosis in renal allograft: An in-depth review. Pediatr Transplant 14:314-325
16. Baum MA (2004) Outcomes after renal transplantation for FSGS in children. Pediatr Transplant 8:329-333 (Pubitemid 39062113)
17. Schachter AD, Harmon WE (2001) Single-center analysis of early recurrence of nephrotic syndrome following renal transplantation in children. Pediatr Transplant 5:406-409 (Pubitemid 33095203)
18. Ingulli E, Tejani A (1991) Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children-a single-center experience. Transplantation 51:401-405
19. Baum MA, Stablein DM, Panzarino VM, Tejani A, Harmon WE, Alexander SR (2001) Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 59:328-333 (Pubitemid 32055241)
20. Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, Maiguel D, Karumanchi SA, Yap HK, Saleem M, Zhang Q, Nikolic B, Chaudhuri A, Daftarian P, Salido E, Torres A, Salifu M, Sarwal MM, Schaefer F, Morath C, Schwenger V, Zeier M, Gupta V, Roth D, Rastaldi MP, Burke G, Ruiz P, Reiser J (2011) Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17:952-960
21. Dall'Amico R, Ghiggeri G, Carraro M, Artero M, Ghio L, Zamorani E, Zennaro C, Basile G, Montini G, Rivabella L, Cardillo M, Scalamogna M, Ginevri F (1999) Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 34:1048-1055
22. Mahesh S, Del Rio M, Feuerstein D, Greenstein S, Schechner R, Tellis V, Kaskel F (2008) Demographics and response to therapeutic plasma exchange in pediatric renal transplantation for focal glomerulosclerosis: A single center experience. Pediatr Transplant 12:682-688
23. Pradhan M, Petro J, Palmer J, Meyers K, Baluarte HJ (2003) Early use of plasmapheresis for recurrent post-transplant FSGS. Pediatr Nephrol 18:934-938 (Pubitemid 37121629)
24. Kershaw DB, Sedman AB, Kelsch RC, Bunchman TE (1994) Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: successful treatment with oral cyclophosphamide. Clin Transplant 8:546-549 (Pubitemid 24361560)
25. Raafat RH, Kalia A, Travis LB, Diven SC (2004) High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children. Am J Kidney Dis 44:50-56 (Pubitemid 38880926)
26. Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, Li J, Mattiazzi A, Ciancio G, Chen L, Zilleruelo G, Abitbol C, Chandar J, Seeherunvong W, Ricordi C, Ikehata M, Rastaldi MP, Reiser J, Burke GW 3rd (2011) Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 3:85ra46
27. Tsagalis G, Psimenou E, Nakopoulou L, Laggouranis A (2011) Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation. Artif Organs 35:420-425
28. Hristea D, Hadaya K, Marangon N, Buhler L, Villard J, Morel P, Martin PY (2007) Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transpl Int 20:102-105
29. Kamar N, Faguer S, Esposito L, Guitard J, Nogier MB, Durand D, Rostaing L (2007) Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports. Clin Nephrol 67:250-254 (Pubitemid 46605375)
30. Gossmann J, Scheuermann EH, Porubsky S, Kachel HG, Geiger H, Hauser IA (2007) Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis. Transpl Int 20:558-562 (Pubitemid 46701081)
31. Meyer TN, Thaiss F, Stahl RA (2007) Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis. Transpl Int 20:1066-1071 (Pubitemid 350043850)
32. Yabu JM, Ho B, Scandling JD, Vincenti F (2008) Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis. Am J Transplant 8:222-227
33. Sakai K, Takasu J, Nihei H, Yonekura T, Aoki Y, Kawamura T, Mizuiri S, Aikawa A (2010) Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient. Clin Transplant 24(Suppl 22):60-65
34. Rodriguez-Ferrero M, Ampuero J, Anaya F (2009) Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis. Transplant Proc 41:2406-2408
35. El-Firjani A, Hoar S, Karpinski J, Bell R, Deschenes MJ, Knoll GA (2008) Post-transplant focal segmental glomerulosclerosis refractory to plasmapheresis and rituximab therapy. Nephrol Dial Transplant 23:425 (Pubitemid 351767399)
36. Freiberger V, Amann K, Heemann U, Frank H (2009) Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation. Transpl Int 22:1110-1113
37. Sethna C, Benchimol C, Hotchkiss H, Frank R, Infante L, Vento S, Trachtman H (2011) Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab. J Transplant. doi: 10.1155/2011/389542
38. Marks SD, McGraw M (2007) Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation? Pediatr Nephrol 22:158-160 (Pubitemid 46138381)
39. Peters HP, van de Kar NC, Wetzels JF (2008) Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature. Neth J Med 66:408-415
40. Araya CE, Dharnidharka VR (2011) The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: A systematic review. J Transplant. doi: 10.1155/2011/374213
41. Kamei K, Ito S, Iijima K (2010) Severe respiratory adverse events associated with rituximab infusion. Pediatr Nephrol 25:1193
42. Vallet H, Houitte R, Azria A, Mariette X (2011) Cytomegalovirus colitis and hypo-IgG after rituximab therapy for rheumatoid arthritis. J Rheumatol 38:965-966
43. Vo KH, Waddell JA, Suda KJ (2011) Rapid development of infusion-related severe hypotension during rituximab therapy. Ann Pharmacother 45:e29
44. Bitzan M, Ouahed JD, Carpineta L, Bernard C, Bell LE (2010) Cryptogenic organizing pneumonia after rituximab therapy for presumed post-kidney transplant lymphoproliferative disease. Pediatr Nephrol 25:1163-1167
45. Bitzan M, Anselmo M, Carpineta L (2009) Rituximab (B-cell depleting antibody) associated lung injury (RALI): A pediatric case and systematic review of the literature. Pediatr Pulmonol 44:922-934
46. Chaumais MC, Garnier A, Chalard F, Peuchmaur M, Dauger S, Jacqz-Agrain E, Deschenes G (2009) Fatal pulmonary fibrosis after rituximab administration. Pediatr Nephrol 24:1753-1755
47. NAPRTCS-2010 Annual Transplant Report. https://web.emmes.com/study/ped/ annlrept/2010-Report.pdf. Accessed on 31 july 2012